October 19, 2010 Steven Hirschfeld, MD, PhD Julia Slutsman, PhD

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

UCSC History. UCSC: A brief history 60s University Placement Committee A lot of field trips/interaction with employers.
Research Administration Capacity Building in an Established Institution Presenter: M.M.Aboud, MD Director of Research and Publications, MUHAS.
Background This linked collaborative is intended to identify opportunities to exchange best practices, administrative and regulatory support models and.
How To Impact Your Research: An Overview of Research Support Services Quincy J. Byrdsong, Terri Hagan, and Alice Owens-Gatlin Research Services Consultants.
Central IRBs An IRB Infoshort June Working Definition  A central IRB is one that serves as IRB of record for all of the sites engaged in a research.
What is a Data and Safety Monitoring Plan and how do I get one? Presented by Office of Human Research Protection.
IRBshare Overview: Investigators Emily Sheffer, MPA Vanderbilt University Medical Center IRBshare Project Manager
Standard 6: Clinical Handover
Multi-Institutional Facilitated IRB Review Philip A. Cola, MA Vice President, Research and Technology University Hospitals Case Medical Center Third Annual.
Yale Clinical Research Management Changes 2008 to Present Day Tesheia H. Johnson, MBA, MHS Associate Director for Clinical Research Yale University School.
ANPRM Single IRB Review mandated for multi-site domestic research P. Pearl O’Rourke, M.D. Partners Health Care.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Philadelphia Allies Against Asthma Michael Schaffer, Coalition Co-Chair.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
Chapter 3 Preparing and Evaluating a Research Plan Gay and Airasian
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami and Affiliated Institutions.
Central IRBs: Ceding IRB Oversight
Kathryn Camp, M.S., R.D., CSP Consultant to the Office of Dietary Supplements National Institutes of Health Secretary’s Advisory Committee on Heritable.
Federalwide Assurance Presentation for IRB Members.
Who’s the Boss? Faculty Advisor or Principal Investigator Supervision versus Student Investigator or Study Coordinator Responsibilities Gwenn Snow, MS,
Ron Sokol, M.D. Principal Investigator, CCTSI Bonnie Walters Executive Director, The Evaluation Center Kathryn Nearing, Ph.D. Associate Director, The Evaluation.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Chesapeake Research Review, Inc. Human Research Protection Experts IRB Services Consultation Education 1 Holding External IRBs Accountable: An Independent.
Taking the Plunge: Facilitating and Monitoring Collaborative Research and IRB Authorization Agreements Charles Hite Director, Biomedical & Research Ethics.
Using Technology to Strengthen Human Subject Protections Patricia Scannell Director, IRB Washington University School of Medicine.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
OHRP Update Ivor Pritchard, Ph.D. Senior Advisor to the Director of OHRP May 2, 2015.
Secretary’s Advisory Committee on Human Subjects Protections (SACHRP) Summary of Responses on: Advanced Notice of Proposed Rulemaking (ANPRM) on Holding.
Research: Intramural and Extramural Jacquelyn Goldberg, JD CIRB Review Board Administrator Clinical Investigations Branch, CTEP Division of Cancer Treatment.
Yale Center for Clinical Investigation: Academic Home to the CTSA Secretary’s Advisory Committee on Human Research Protections (SACHRP) Presentation Tesheia.
PSO Overview for Executives (Presenter) (Date) Center for Patient Safety Toolkit for PSO Participation, Section 4.
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
The Research Subject Advocate (RSA). Pictured, left to right: Andrea Saltzman, RN; Enrico Cagliero, MD; Debi Dunkless.
Status of SACHRP Recommendations July 2003-October 2008 Meeting of the Secretary’s Advisory Committee on Human Research Protections October 27, 2008 Michael.
The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003.
OHRP Guidance and Policy Development Process Secretary’s Advisory Committee on Human Research Protections Meeting October 27, 2008 Irene Stith-Coleman,
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
Copyright FDA Inspections: Where Do Things Go Wrong? Diana Naser RN, MS, CCRP Executive Director Clinical Research Administration Clinical Research.
Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.
Wisconsin IRB Consortium (WIC): a model for multi-site IRB review Nichelle Cobb, PhD Director, Health Sciences IRBs University of Wisconsin-Madison Secretary’s.
SACHRP PANEL: HOLDING EXTERNAL IRBS ACCOUNTABLE David L. Wynes, Ph.D. Vice President for Research Administration Emory University July 21, 2009.
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
Updates in Research Protections Karen Allen Director, Research Protections Office of Research November
2012 State of the IRB Boston University Charles River Campus (CRC) Cynthia J. Monahan, MBA, CIP Director, Institutional Review Board.
August 20, 2008 Clinical and Translational Science Awards (CTSA) CTSA Evaluation Approach Institute for Clinical & Translational Research (ICTR)
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.
OHRP’s Compliance Oversight Procedures
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.
VA Central IRB MOU Webinar K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
Multi-site Research - Central/Single IRBs - Data sharing questions P. Pearl O’Rourke, MD Partners HealthCare October 26, 2015.
IRB Open House: Implementation of Single IRB Review
Overview: IRBshare  IRBchoice
University Career Services Committee
Ceding Review: Using the new SmartIRB Online Reliance System
JH Trial Innovation Unit (TIU)
Preparing for NIH’s sIRB Review Requirements
Clinical and Translational Science Awards Program
Changes to the Common Rule and Single IRB (sIRB)
IRB Harmonization 2016 Review
CTSA27 So you want COMIRB to be your sIRB: What you need to know.
NAACCR 2014 Call for Data Webinar
Presentation transcript:

Overview of the Federation Model for IRB Review of the National Children’s Vanguard Study P October 19, 2010 Steven Hirschfeld, MD, PhD Julia Slutsman, PhD National Children’s Study Program Office Eunice Kennedy Shriver National Institute of Child Health and Human Development

Overview of Presentation A Brief History and Background of the Federation Model Introduction to the National Children’s Study (NCS) Vanguard Study Description of Federation Model as implemented in the NCS Vanguard Study Status of Federation of NCS IRBs Membership Evaluation Resources for Developing a Federation IRBs Generic Federation of IRBs Toolkit

Brief History of the Federation Model of IRB Review The Federation of NCS IRBs is modeled after an approach to centralized review for multi-site studies proposed by institutions receiving Clinical and Translational Science Awards (CTSA) The Federated model was first presented to the Secretary's Advisory Committee on Human Research Protections (SACHRP) during its July 2009 meeting Federation model MOU and compact have been reviewed by OHRP This model of IRB review of multi-site studies will be implemented as a pilot effort with institutions participating in the NCS as well as the possibility of additional institutions with CTSA awards and NICHD networks

What are the guiding principles for the Federated Model? Transparency & Communication: Determinations and documentation are shared across all reviewing IRBs Flexibility: Level of participation in Federation IRBs is determined by each local FWA holding institution at a given Study Location. Tiers of participation specified in Memorandum of Understanding (MOU) Coordination: The Federation is managed by the NCS Federation IRB Operations Center within the NCS Program Office Operations center creates submission packages, FAQs, standard operating procedures, templates Trust: Shared commitment to protection of NCS participants Codified in Federation Compact

Tiers of Participation in Federation of National Children’s Study IRBs Review Responsibilities of Local IRB Review Responsibilities of Lead IRB IRB of Record (NICHD or Local IRB) MOU Required (Y or N) 1 Reliance on NICHD IRB as IRB of Record Communication of local context issues to NICHD IRB via NCS IRB Operations Center. Initial reviews Continuing reviews Protocol amendments initiated by NCS Program Office Protocol amendments initiated by local Principal Investigator** Serious Adverse Events** DMC (Data Monitoring Committee) reports Unanticipated event reporting to OHRP** NICHD Yes 2 Facilitated or full local review Review of materials (initial reviews, amendments, continuing reviews) approved by NICHD IRB Communication of local context issues to NICHD IRB via NCS IRB Operations Center Local implementation review and oversight Protocol amendments initiated by local Principal Investigator (if local IRB is IRB of record) Unanticipated event reporting to OHRP Serious Adverse Events Local IRB and, if desired, NICHD IRB 3 Reliance on local review Local IRB NIH Eunice K. Shriver National Institute of Children’s Health and Development (NICHD) intramural IRB is lead IRB for Tier 1 *Adherence to principles in Compact required for all tiers; **For Tier 1 institutions only

IRB(s) of Record by Tier of Participation Level of Participation Reliance/IRB of Record Tier 1 Reliance on NICHD IRB as the IRB of Record Tier 2 Routine local review and option to designate NICHD IRB as the IRB of record, in addition to the local Institution’s IRB, to allow a facilitated review Tier 3 Local institutions IRB is the IRB of record

Reporting of Unanticipated Events by Tier of Participation Reviewing Responsibilities Unanticipated Events Reporting Responsibilities of Unanticipated Events to HHS and OHRP Reporting Responsibilities of Study-Wide Unanticipated Problems to HHS and OHRP 1 Reliance on NICHD IRB as IRB of Record NICHD IRB NCS Study Director 2 Routine local review and option to designate NICHD IRB as the IRB of Record in addition to the local Institution’s IRB Local Institution 3 Reliance on local review

What are the advantages to an institution/IRB/investigator of participating in this model? The advantages of the Federation vary depending on the level of participation an institution accepts As a central goal of the Federation of IRBs, there will be a reduction in duplication of review and a reduction of administrative burden at the local level while maintaining the highest standard of human subject protections review and oversight Attention to local context is maintained and becomes the priority of the IRB. Mechanism to provide local context is set up between local institution/IRB and Operations Center With less responsibility to provide a duplicative review at the local level, approval turnaround is anticipated to improve Over time, enhanced communication and trust across disparate IRBs

Federated IRB Participation in National Children’s Study Additional Membership from Study Location Hospitals, Birth Centers and Contract Research Organizations is Expected Please note that numbers include institutions that have either submitted signed MOUs or are in the process of submitting MOUs and have indicated their Tier of planned participation with some certainty N=36 Study Centers Participating in National Children’s Study Vanguard Phase

Evaluation of Performance of Federation of NCS IRBS Formal evaluation of the performance of the Federation of NCS IRBs will be conducted jointly by the NCS Program Office and the NICHD Office of Science Policy, Analysis & Communication Mixed Methods Approach: Quantitative and Qualitative methods will be used to assess membership and variation in process among tiers of participation, barriers to participation, stakeholder and member experiences with Federation Examples of Planned Analyses: Perceptions of stakeholders about the value and functioning of the Federation, barriers to participation Length of IRB submission review cycle Content of stipulations raised in approval letters from Federation member IRBs

Preliminary, Anecdotal Data from Implementation of Federation of NCS IRBs Positive response from most NCS Study Center Institutions and principal investigators Early adapters seems to be choosing participation in Tier 1 Institutions participating in NCI Studies reviewed by the NCI CIRB or Pediatric CIRB seem more comfortable with Tier 1 participation AAHRPP Accreditation status is a barrier for establishing a reliance on the NICHD IRB for some but not all accredited institutions Member institutions interested in knowing tiers of Participation selected by comparable institutions prior to making a decision

Resources The Federation of IRBs Toolkit Customizable materials that are required for creating and executing memorandums of understanding necessary to establish a Federation of IRBs that works collaboratively to centralize high quality human subject protections review for multi-site research protocol(s) Inquiries: hirschfs@mail.nih.gov